News Focus
News Focus
Followers 48
Posts 12087
Boards Moderated 0
Alias Born 09/12/2017

Re: $5.95akadawson-m post# 232370

Thursday, 05/16/2024 4:34:25 PM

Thursday, May 16, 2024 4:34:25 PM

Post# of 236638
Yes lets review the pumper talk bolded in red---

Over the next six months, we expect to commence at least one, and potentially two clinical trials. The prospective clinical trials, in order of priority, are: (i) a Phase II study of leronlimab in patients with relapsed/refractory microsatellite stable colorectal cancer; and (ii) a Phase II study exploring leronlimab’s effects on inflammation. The Company’s priority will be the oncology trial which, if successful, will put us on track towards a commercial approval of leronlimab in that indication.

This sentence: "The Company’s priority will be the oncology trial which, if successful, will put us on track towards a commercial approval of leronlimab in that indication."


(sigh) Dupes will never learn....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News